Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02135211 · ClinicalTrials.gov registry record · NA
Healthy Directions After Lung Surgery Pilot
A NA study of Carcinoma, Non-Small Cell Lung, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 2
- Study locations
NCT02135211 is a NA study of Carcinoma, Non-Small Cell Lung that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 42 participants, below the 324-participant average among 130 other Carcinoma, Non-Small Cell Lung trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02135211, a NA study of Carcinoma, Non-Small Cell Lung, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective of this proposal is to test the feasibility and acceptability of a lifestyle risk reduction intervention for patients with lung cancer receiving surgical treatment. This study will provide the preliminary data needed to conduct a larger randomized controlled trial that tests an innovative, multidisciplinary intervention that has the potential to transform the standard of care for patients receiving surgical treatment for lung cancer.
Conditions Studied
Interventions
- BEHAVIORAL Lifestyle counseling
Study Locations (2)
Massachusetts
- Brigham & Woman's Hospital - Boston
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2012-09 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02135211
The ClinicalTrials.gov registry entry for NCT02135211 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 324-participant average among 130 other Carcinoma, Non-Small Cell Lung trials with a reported enrollment target (87% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Carcinoma, Non-Small Cell Lung appearing as the primary indexed condition, and to 1 intervention - of which Lifestyle counseling is the first listed.
NCT02135211 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02135211 about?
NCT02135211 is a clinical study titled "Healthy Directions After Lung Surgery Pilot". The objective of this proposal is to test the feasibility and acceptability of a lifestyle risk reduction intervention for patients with lung cancer receiving surgical treatment. This study will provide the preliminary data needed to conduct a larger randomized controlled trial that tests an innovat...
What is the current status of trial NCT02135211?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2012-09. Estimated completion is 2015-06.
What conditions does trial NCT02135211 study?
This clinical trial studies the following conditions: Carcinoma, Non-Small Cell Lung.
What interventions are being tested in trial NCT02135211?
The interventions under investigation include: Lifestyle counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02135211?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02135211 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carcinoma, Non-Small Cell Lung
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Confocal Laser Endomicroscopy VERification
RECRUITING · NA
-
Patient-centered, Optimal Integration of Survivorship and Palliative Care
RECRUITING · NA
-
Once Weekly Radiation for Lung Cancer With Chemotherapy
COMPLETED · NA
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RECRUITING · Phase 1
-
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
RECRUITING · Phase 1
-
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.